Clinical Trial Update: Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Bupropion-enhanced contingency management for cocaine dependence has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: Johns Hopkins University | Conditions: Substance Abuse, Cocaine Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-20